Replies to post #396072 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

“Cubicin (Daptomycin), has generated over $1 billion in annual sales and is an antibiotic that Brilacidin has performed comparably to, both in the literature and in clinical trials, where Brilacidin went head-to-head with it in Phase 2”

Ehrlich forget to mention that brilacidin caused twice as many adverse events as daptomycin and had six serious adverse events against none for daptomycin (although that latter finding was apparently one of those one in several million to one random occurrences that just happen when the principal investigator is also a company employee).

[leavetheguntakethecannolis]

There has been a extraordinary, ubiquitous effort to indicate IPIX is not Regeneron. Why is that?

[frenchbroad]

*As for Regeneron, consider this quote from it's S-3 Registration Statement filed in 2000:
"As of December 31,1999, we had 437 full-time employees, 82 of whom hold a Ph.D. and/or M.D. degree."*

This is super funny. If this was the Ipix situation some in social media would say:
*This company has 82 expensive doctors who sit in the pool all day and do nothing! We have no approvals for 12 years!! The science is garbage and the share price is super low and this company is dead. The CEO is corrupt and stupid. Show me the approvals!*

And there would be no approvals for another 8 years.

But the market and the money eventually found R**n because the science in fact was good. The same will happen with Ipix. I am happy with the science that Ipix and I own.